Loading Events

« All Events

  • This event has passed.

2nd Immune Effector Cell Therapy in Multiple Myeloma Workshop

May 7 - May 8

Within a very short period of time, there has been a tremendous advance in development of cellular immunotherapies in multiple myeloma (MM). As we have observed during our event last year, a number of groups have presented their data on CAR T-cell therapy in MM. Although the studies are currently small in size, they are accruing patients very quickly, both in the United States and globally.

These developments have highlighted the need for a focused discussion about the state-of-the-art in immune and cellular therapies. With this in mind, the International Myeloma Society (IMS) is organizing the 2nd Immune Effector Cell Therapy in Multiple Myeloma Workshop. This two-day meeting will review CAR-T clinical data and promising preclinical leads, gain consensus on issues in management of toxicity, and discuss ongoing and future clinical trials. This year we are also including a session on T cell-engaging bispecific antibody-based approaches.

Details

Start:
May 7
End:
May 8
Website:
https://www.myelomasociety.org/meetings/upcoming-meetings.php

Venue

Sheraton Boston Hotel
39 Dalton Street
Boston, 02199 United States
Website:
https://www.marriott.com/hotels/travel/bosbo-sheraton-boston-hotel/

Organizer

International Myeloma Society
Phone:
617-632-5272
Email:
International Myeloma Society
Website:
https://www.myelomasociety.org/